Biomarkers of vaccine
safety and efficacy
in vulnerable populations
October, 5-6 2023
Co-hosted by the Precision Vaccines Program of Boston Children’s Hospital (BCH; Boston, MA) and Ospedale Pediatrico Bambino Gesù (OPBG; Rome, Italy), the Biomarkers of vaccine safety and efficacy in Vulnerable Population Conference is developed by the IPVC Organizing Committee led by Prof. Ofer Levy of Boston Children’s Hospital and Prof. Paolo Palma of Ospedale Pediatrico Bambino Gesù. This in-person conference will gather experts in vaccinology and immunology from academia, government and industry to provide insight on the conference theme:
Precision Vaccines: Biomarkers of vaccine safety and efficacy in vulnerable populations
Vaccines prevent ~3 million deaths every year and are crucial in combating antimicrobial resistance. Optimizing implementation of existing vaccines could help avert up to 1.5 million additional deaths as well as disabilities resulting from vaccine preventable diseases. Immunologically vulnerable populations (VPs), including pregnant women, term and preterm newborns and young infants, older adults and patients affected by chronic or immunocompromising conditions are frequently under-vaccinated and/or at risk of reduced vaccine efficacy, presenting a major health and economic burden to society. Vaccine development programs mainly focus on healthy populations; therefore, vaccination strategies are often based on data arising from healthy study participants. The goal of the 4th International Precision Vaccines Conference is to discuss and reflect on recent studies of vaccine safety and immunogenicity relevant to vulnerable populations. We welcome abstracts from different disciplines, spanning scientific areas in epidemiology, basic immunology, systems vaccinology, and human in vitro modeling. We encourage submissions focused on the following themes:
- Host-, pathogen- or drug-related mechanisms that can affect responsiveness to vaccines in VPs
- Safety and immunogenicity of existing and novel vaccines for different pathological conditions and age groups, represented by VPs
- Proposed new biomarkers of safety and efficacy to guide effective optimal vaccination of VPs
Parco dei Principi Grand Hotel & Spa
Via G. Frescobaldi, 5 – 00198 Roma, Italy
Paolo Palma, MD, PhD
Ofer Levy, MD, PhD
Stanley Plotkin, MD
Olubukola “Bukky” Idoko, MD, PhD, MSc
Nicola Cotugno MD, PhD
Asimenia Angelidou, MD, PhD
Nicole Lewis, Giulia Neccia, Jennifer Faudella, Mehmet Saluvan, Amy Sherman
Galit Alter, Ph.D.
Philip Goulder, FRCPCH, DPhil, FMedSci
Jessica Lasky-Su DSc, MS
Ofer Levy, M.D., Ph.D.
Paolo Palma, M.D., Ph.D.
Sir Andrew Pollard
Rino Rappuoli, Ph.D.
Scott Tebbutt, Ph.D.
Claire Thorne Msc, PhD
Karina Top, MD, MSc, FRCPC
Pierre Van Damme, M.D., Ph.D.
Ivan Zanoni, Ph.D.
Early bird pricing is live! Secure your spot now. Prices will go up in the coming months.
|Attendee||€ 100,00||€ 450,00||€ 750,00|
We are accepting abstract submissions for IPVC posters and/or oral presentations. Abstracts will be included in the conference brochure.
Submission deadline: 8 June 2023
- in PDF or Microsoft Word format, Arial 11-point font, 0.5-inch margins.
- not to exceed 500 words, excluding title, authors, and affiliations (please provide these)
- extra page for tables, figures, and references is permitted
- additional questions, please email firstname.lastname@example.org
Hotels suggested near the meeting venue
For further information, please get in touch with the hotel.
Sponsorship & Exhibitor Levels & Pricing
|Sponsorship Levels||€ 2.500,00||€ 5.000,00||€ 10.000,00||€ 20.000,00|
Unrestricted Educational Grant
– If you are from Europe/Other Countries contact: email@example.com
– For abstract submission contact: firstname.lastname@example.org